08/07/2025 6:05 AM | Cartesian Therapeutics, Inc. (Filer) Cartesian Therapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
08/07/2025 6:08 AM | Cartesian Therapeutics, Inc. (Filer) Cartesian Therapeutics (Filer)
| Form 10-Q General form for quarterly reports under Section 13 or 15(d) | |
06/16/2025 6:06 AM | Cartesian Therapeutics, Inc. (Filer) Cartesian Therapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
05/30/2025 6:02 AM | Cartesian Therapeutics, Inc. (Filer) Cartesian Therapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
05/08/2025 6:04 AM | Cartesian Therapeutics, Inc. (Filer) Cartesian Therapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
05/08/2025 6:05 AM | Cartesian Therapeutics, Inc. (Filer) Cartesian Therapeutics (Filer)
| Form 10-Q General form for quarterly reports under Section 13 or 15(d) | |
05/08/2025 6:13 AM | Cartesian Therapeutics, Inc. (Filer) Cartesian Therapeutics (Filer)
| Form S-8 Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans | |
04/29/2025 7:01 AM | Cartesian Therapeutics, Inc. (Filer) Cartesian Therapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
04/28/2025 3:41 PM | Cartesian Therapeutics, Inc. (Filer) Cartesian Therapeutics (Filer)
| Form DEFA14A | |
04/25/2025 1:57 PM | Cartesian Therapeutics, Inc. (Subject) Cartesian Therapeutics (Subject) JPMORGAN CHASE & CO (Filed by) JPMORGAN CHASE & CO (Filed by)
| Form SCHEDULE 13G | |
04/16/2025 3:35 PM | Cartesian Therapeutics, Inc. (Issuer) Cartesian Therapeutics (Issuer) English Emily (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
|
04/11/2025 4:29 PM | Cartesian Therapeutics, Inc. (Issuer) Cartesian Therapeutics (Issuer) SPRINGER TIMOTHY A (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
04/08/2025 6:04 AM | Cartesian Therapeutics, Inc. (Filer) Cartesian Therapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
03/20/2025 6:50 PM | Cartesian Therapeutics, Inc. (Issuer) Cartesian Therapeutics (Issuer) SPRINGER TIMOTHY A (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
03/13/2025 6:04 AM | Cartesian Therapeutics, Inc. (Filer) Cartesian Therapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
03/13/2025 6:06 AM | Cartesian Therapeutics, Inc. (Filer) Cartesian Therapeutics (Filer)
| Form 10-K Annual report pursuant to Section 13 or 15(d) | |
03/03/2025 5:59 AM | Cartesian Therapeutics, Inc. (Filer) Cartesian Therapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
02/12/2025 8:28 AM | Cartesian Therapeutics, Inc. (Subject) Cartesian Therapeutics (Subject) FMR LLC (Filed by)
| Form SCHEDULE 13G/A | |
01/27/2025 6:04 AM | Cartesian Therapeutics, Inc. (Filer) Cartesian Therapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
01/15/2025 3:25 PM | Cartesian Therapeutics, Inc. (Subject) Cartesian Therapeutics (Subject) SPRINGER TIMOTHY A (Filed by)
| Form SCHEDULE 13D/A | |
01/15/2025 3:08 PM | Cartesian Therapeutics, Inc. (Issuer) Cartesian Therapeutics (Issuer) SPRINGER TIMOTHY A (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
01/13/2025 11:15 PM | Cartesian Therapeutics, Inc. (Filer) Cartesian Therapeutics (Filer)
| Form EFFECT | |
01/13/2025 11:15 PM | Cartesian Therapeutics, Inc. (Filer) Cartesian Therapeutics (Filer)
| Form EFFECT | |
01/13/2025 3:09 PM | Cartesian Therapeutics, Inc. (Issuer) Cartesian Therapeutics (Issuer) Jewell Christopher M (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
01/13/2025 6:04 AM | Cartesian Therapeutics, Inc. (Filer) Cartesian Therapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
01/09/2025 11:15 PM | Cartesian Therapeutics, Inc. (Filer) Cartesian Therapeutics (Filer)
| Form EFFECT | |
01/09/2025 11:15 PM | Cartesian Therapeutics, Inc. (Filer) Cartesian Therapeutics (Filer)
| Form EFFECT | |
01/09/2025 11:15 PM | Cartesian Therapeutics, Inc. (Filer) Cartesian Therapeutics (Filer)
| Form EFFECT | |
01/10/2025 5:00 AM | Cartesian Therapeutics, Inc. (Filer) Cartesian Therapeutics (Filer)
| Form POS AM | |
01/10/2025 5:01 AM | Cartesian Therapeutics, Inc. (Filer) Cartesian Therapeutics (Filer)
| Form POS AM | |
01/08/2025 3:33 PM | Cartesian Therapeutics, Inc. (Filer) Cartesian Therapeutics (Filer)
| Form 424B7 | |
01/08/2025 3:38 PM | Cartesian Therapeutics, Inc. (Filer) Cartesian Therapeutics (Filer)
| Form 424B7 | |
01/08/2025 3:30 PM | Cartesian Therapeutics, Inc. (Filer) Cartesian Therapeutics (Filer)
| Form 424B3 | |
01/07/2025 7:04 PM | Cartesian Therapeutics, Inc. (Issuer) Cartesian Therapeutics (Issuer) Davis Blaine (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
01/07/2025 7:04 PM | Brunn Carsten (Reporting) Cartesian Therapeutics, Inc. (Issuer) Cartesian Therapeutics (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
01/07/2025 7:05 PM | Cartesian Therapeutics, Inc. (Issuer) Cartesian Therapeutics (Issuer) English Emily (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
01/07/2025 7:05 PM | Cartesian Therapeutics, Inc. (Issuer) Cartesian Therapeutics (Issuer) Jewell Christopher M (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
01/07/2025 7:05 PM | Cartesian Therapeutics, Inc. (Issuer) Cartesian Therapeutics (Issuer) Miljkovic Milos (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
01/07/2025 7:05 PM | Cartesian Therapeutics, Inc. (Issuer) Cartesian Therapeutics (Issuer) Kurtoglu Metin (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
01/06/2025 3:21 PM | Brunn Carsten (Reporting) Cartesian Therapeutics, Inc. (Issuer) Cartesian Therapeutics (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
12/30/2024 3:14 PM | Cartesian Therapeutics, Inc. (Issuer) Cartesian Therapeutics (Issuer) Singer Michael (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
|
12/30/2024 3:11 PM | Cartesian Therapeutics, Inc. (Issuer) Cartesian Therapeutics (Issuer) English Emily (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
12/23/2024 7:22 PM | Cartesian Therapeutics, Inc. (Subject) Cartesian Therapeutics (Subject) SPRINGER TIMOTHY A (Filed by)
| Form SCHEDULE 13D/A | |
12/23/2024 4:20 PM | Cartesian Therapeutics, Inc. (Issuer) Cartesian Therapeutics (Issuer) SPRINGER TIMOTHY A (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
12/13/2024 3:16 PM | Cartesian Therapeutics, Inc. (Filer) Cartesian Therapeutics (Filer)
| Form S-3 Registration statement under Securities Act of 1933 | |
12/11/2024 3:28 PM | Cartesian Therapeutics, Inc. (Issuer) Cartesian Therapeutics (Issuer) Kurtoglu Metin (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
12/10/2024 3:21 PM | Cartesian Therapeutics, Inc. (Subject) Cartesian Therapeutics (Subject) Kurtoglu Metin (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
12/09/2024 3:36 PM | Cartesian Therapeutics, Inc. (Subject) Cartesian Therapeutics (Subject) Kurtoglu Metin (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
12/03/2024 5:03 AM | Cartesian Therapeutics, Inc. (Filer) Cartesian Therapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
11/21/2024 5:50 PM | Cartesian Therapeutics, Inc. (Issuer) Cartesian Therapeutics (Issuer) Jewell Christopher M (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
11/21/2024 5:51 PM | Cartesian Therapeutics, Inc. (Issuer) Cartesian Therapeutics (Issuer) Singer Michael (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
11/21/2024 5:52 PM | Cartesian Therapeutics, Inc. (Issuer) Cartesian Therapeutics (Issuer) Kurtoglu Metin (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
11/21/2024 3:45 PM | Cartesian Therapeutics, Inc. (Subject) Cartesian Therapeutics (Subject) Kurtoglu Metin (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
11/18/2024 8:44 PM | Cartesian Therapeutics, Inc. (Subject) Cartesian Therapeutics (Subject) SPRINGER TIMOTHY A (Filed by)
| Form SC 13D/A | |
11/18/2024 6:28 PM | Cartesian Therapeutics, Inc. (Issuer) Cartesian Therapeutics (Issuer) Miljkovic Milos (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
11/18/2024 6:32 PM | Cartesian Therapeutics, Inc. (Issuer) Cartesian Therapeutics (Issuer) Kurtoglu Metin (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
11/18/2024 6:35 PM | Cartesian Therapeutics, Inc. (Issuer) Cartesian Therapeutics (Issuer) SPRINGER TIMOTHY A (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
11/18/2024 6:23 PM | Cartesian Therapeutics, Inc. (Issuer) Cartesian Therapeutics (Issuer) Jewell Christopher M (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
11/18/2024 3:24 PM | Cartesian Therapeutics, Inc. (Subject) Cartesian Therapeutics (Subject) Kurtoglu Metin (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
11/15/2024 4:07 PM | Cartesian Therapeutics, Inc. (Subject) Cartesian Therapeutics (Subject) Kurtoglu Metin (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
11/07/2024 6:31 AM | Cartesian Therapeutics, Inc. (Filer) Cartesian Therapeutics (Filer)
| Form S-8 Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans | |
11/07/2024 6:06 AM | Cartesian Therapeutics, Inc. (Filer) Cartesian Therapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
11/07/2024 6:19 AM | Cartesian Therapeutics, Inc. (Filer) Cartesian Therapeutics (Filer)
| Form 10-Q General form for quarterly reports under Section 13 or 15(d) | |
10/15/2024 3:53 PM | Cartesian Therapeutics, Inc. (Issuer) Cartesian Therapeutics (Issuer) Kalayoglu Murat (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
10/15/2024 3:30 PM | Cartesian Therapeutics, Inc. (Subject) Cartesian Therapeutics (Subject) Kalayoglu Murat (Filed by)
| Form SC 13D/A | |
10/15/2024 3:43 PM | Cartesian Therapeutics, Inc. (Issuer) Cartesian Therapeutics (Issuer) Hoge Elizabeth (Reporting) Seven One Eight Three Four Irrevocable Trust (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
10/04/2024 5:08 PM | Cartesian Therapeutics, Inc. (Subject) Cartesian Therapeutics (Subject) SPRINGER TIMOTHY A (Filed by)
| Form SC 13D/A | |
10/04/2024 4:58 PM | Cartesian Therapeutics, Inc. (Issuer) Cartesian Therapeutics (Issuer) SPRINGER TIMOTHY A (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
10/01/2024 11:15 PM | Cartesian Therapeutics, Inc. (Filer) Cartesian Therapeutics (Filer)
| Form EFFECT | |
10/01/2024 3:36 PM | Cartesian Therapeutics, Inc. (Filer) Cartesian Therapeutics (Filer)
| Form 424B7 | |
09/27/2024 3:13 PM | Cartesian Therapeutics, Inc. (Issuer) Cartesian Therapeutics (Issuer) SPRINGER TIMOTHY A (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
09/27/2024 3:20 PM | Cartesian Therapeutics, Inc. (Subject) Cartesian Therapeutics (Subject) SPRINGER TIMOTHY A (Filed by)
| Form SC 13D/A | |
09/26/2024 6:02 AM | Cartesian Therapeutics, Inc. (Filer) Cartesian Therapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
09/23/2024 6:03 AM | Cartesian Therapeutics, Inc. (Filer) Cartesian Therapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |